Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
23.53
+0.40 (1.73%)
At close: Aug 22, 2025, 4:00 PM
23.14
-0.39 (-1.66%)
After-hours: Aug 22, 2025, 5:41 PM EDT
Progyny Market Cap
Progyny has a market cap or net worth of $2.02 billion as of August 22, 2025. Its market cap has increased by 7.49% in one year.
Market Cap
2.02B
Enterprise Value
1.75B
1-Year Change
7.49%
Ranking
Category
Stock Price
$23.53
Market Cap Chart
Since October 25, 2019, Progyny's market cap has increased from $1.31B to $2.02B, an increase of 54.46%. That is a compound annual growth rate of 7.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 2.02B | 37.73% |
| Dec 31, 2024 | 1.47B | -58.78% |
| Dec 29, 2023 | 3.56B | 23.15% |
| Dec 30, 2022 | 2.89B | -36.45% |
| Dec 31, 2021 | 4.55B | 23.98% |
| Dec 31, 2020 | 3.67B | 59.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |